Pharmaceutical composition for treating senile dementia and preparation method thereof

A technology for senile dementia and composition, which is applied in the field of pharmaceutical composition and its preparation, pharmaceutical composition for treating senile dementia and its preparation field, can solve problems such as unsatisfactory effect, and achieve the effect of treating and preventing senile dementia

Inactive Publication Date: 2014-01-01
钱昌美
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] There are some drugs for the treatment of senile dementia, but the effect is not satisfactory

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment approach

[0061] Therefore, according to some embodiments of the present invention, a method of preparing the above-mentioned pharmaceutical composition for a permanent cure, it comprises the following steps:

[0062] (1) Selected authentic medicinal materials: It is required to use superior authentic Chinese medicinal materials, remove impurities, and conduct identification and sample quality comparison inspection according to the provisions of the National Pharmacopoeia.

[0063] (2) Finishing: process Liedang, Angelica dahurica and optional Chuanxiong, Pueraria, Cimicifuga, Bupleurum, Ligusticum, Ginkgo Leaf, and Rhodiola to 10-40 meshes, mix and add 5-10 times of water Soak 2-3cm higher than the medicinal surface, heat and decoct for 2-3 hours, then filter, add 3-6 times the amount of water to the medicinal residue, heat and decoct for the second time, filter after 1-2 hours, combine the filtrates, evaporate at low temperature, and concentrate to the original ?, add 95% ethanol and mi...

Embodiment 1

[0068] Prepare pharmaceutical composition of the present invention according to following formula:

[0069] Liedang 50 parts by weight, Angelica dahurica 50 parts by weight.

[0070] That is, the pharmaceutical composition contains the monarch drug as an active ingredient.

[0071] Wherein the preparation steps include:

[0072] (1) Selected authentic medicinal materials: It is required to use superior authentic Chinese medicinal materials, remove impurities, and conduct identification and sample quality comparison inspection according to the provisions of the National Pharmacopoeia.

[0073] (2) Finishing: Grind Angelica dahurica and Liedang to 20 mesh, add 8 times of water after mixing, soak 2-3cm higher than the medicine surface, heat and decoct for 2 hours, filter, add 4 times the amount of water to the medicine residue, the second time Heat and decoct for 1 hour, filter, combine the filtrates, evaporate at low temperature, concentrate to the original volume of ?, add 95...

Embodiment 2

[0076] Prepare pharmaceutical composition of the present invention according to following formula:

[0077] 50 parts by weight of Liedang, 50 parts by weight of Angelica dahurica, 30 parts by weight of Rhizoma Chuanxiong, 30 parts by weight of Radix Puerariae, 50 parts by weight of Cimicifuga, 50 parts by weight of Bupleuri, and 50 parts by weight of Ligusticum edulis.

[0078] That is, the pharmaceutical composition comprises the principal drug and the subordinate drug as active ingredients.

[0079] Wherein the preparation steps include:

[0080] (1) Selected authentic medicinal materials: It is required to use superior authentic Chinese medicinal materials, remove impurities, and conduct identification and sample quality comparison inspection according to the provisions of the National Pharmacopoeia.

[0081] (2) Finishing: Grind Liedang, Angelica dahurica, Chuanxiong, Pueraria, Cimicifuga, Bupleurum, and Ligusticum edulis to 20 mesh, add 8 times of water after mixing, soa...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates a to pharmaceutical composition which comprises the following bulk drugs: orobanche coerulescens steph, angelica dahurica, and optionally selected ligusticum wallichii, radix puerariae, cimicifuga foetida, radix bupleuri, rhizoma ligustici, ginkgo biloba, pilose antler, rhodiola root, donkey-hide gelatin and red ginseng tails. The pharmaceutical composition is applicable to treat and prevent senile dementia.

Description

technical field [0001] The invention belongs to the technical field of traditional Chinese medicine preparations, and relates to a pharmaceutical composition and a preparation method thereof. Specifically, the invention relates to a pharmaceutical composition for treating senile dementia and a preparation method thereof. Background technique [0002] Alzheimer's disease is a progressive and fatal neurodegenerative disease. The clinical manifestations are deteriorating cognitive and memory functions, progressive decline in daily life ability, and various neuropsychiatric symptoms and behavioral disorders. According to the United Nations Information Office's survey on the global elderly, about 10% of the elderly over the age of 65 suffer from Alzheimer's disease. [0003] Alzheimer's disease is mainly divided into three categories: primary senile dementia, dementia caused by cerebrovascular disease (vascular dementia), and mixed dementia. [0004] The brains of Alzheimer's p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/71A61P25/28
CPCA61K35/12A61K36/16A61K36/23A61K36/232A61K36/234A61K36/25A61K36/258A61K36/48A61K36/488A61K36/64A61K36/71
Inventor 钱昌美
Owner 钱昌美
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap